Latest Licensing News

AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.

Stelar Metals has secured environmental approval for its inaugural ~3,000m Reverse Circulation drilling campaign at the Hill of Leaders Tungsten Project, set to begin in August 2026. This marks the first deep drilling beneath a high-grade tungsten system with significant strike and width in the Northern Territory.

TMK Energy reported a record gas output of around 28,000 scfd in June 2026, backed by a fully funded 2026 work program and key management hires. The company is progressing a 1MW gas-to-power pilot with Mongolia’s largest LPG distributor.

Battery Age Minerals has identified multiple priority exploration targets at its Apex Project in Utah, submitted new drilling permits for Austria’s Bleiberg site, finalised a commercial germanium technology licence, and gained entry to a US defense consortium, underpinning its integrated germanium strategy.

NeuroScientific Biopharmaceuticals achieved an 80% clinical response rate in fistulising Crohn’s disease patients treated under the TGA Special Access Scheme, advancing plans for Phase 2 trials and manufacturing scale-up.

Alliance Nickel has kicked off vat leach testing at its NiWest Nickel-Cobalt Project, aiming to slash capital costs, while raising $2.4 million through a partial entitlement offer and extending loan facilities to mid-2027.

Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.

Rent.com.au has delivered a second consecutive positive operating cashflow quarter, driven by strong RentBond® loan growth and recurring revenue surpassing $1 million per quarter.

Clean TeQ Water has marked a milestone with its inaugural recurring revenue from ATA® technology and a 45% jump in quarterly customer receipts, underpinned by contract wins and project progress across global water and critical minerals markets.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.